Connor, Clark & Lunn Investment Management Ltd.

Position in CMPX — Compass Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in CMPX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,147,071

-$1,486,386 QoQ

Shares Held

523,777

+5.2% QoQ

Ownership

0.291%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 213 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. CMPX ranks #62 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,147,071	523,777	+5.2%	Shares	Sole	2026-08-13
2026-03-31	$2,633,457	497,818	+159.7%	Shares	Sole	2026-05-11
2025-12-31	$1,029,557	191,724	+22.2%	Shares	Sole	2026-02-10
2024-12-31	$227,462	156,871	-32.4%	Shares	Sole	2025-02-10
2024-09-30	$426,970	232,049	+0.2%	Shares	Sole	2024-11-08
2024-06-30	$231,525	231,525	-3.9%	Shares	Sole	2024-08-09
2024-03-31	$476,784	240,800	+13.1%	Shares	Sole	2024-05-09
2023-12-31	$332,225	212,965	+60.4%	Shares	Sole	2024-02-09
2023-09-30	$261,600	132,792	+15.4%	Shares	Sole	2023-11-13
2023-06-30	$365,846	115,046	+410.2%	Shares	Sole	2023-08-10
2023-03-31	$73,741	22,551	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.